2-CHLORO-1-(3-ETHYL-2
Crystal structure of 2 chloro 1 (3 ethyl 2,6 diphenylpiperidin 1 yl)ethanone
9
Ethyl trans 3 (2 chloro 6,7 dimethylquinolin 3 yl) 1 cyclohexylaziridine 2 carboxylate
9
Crystal structure of ethyl 2 chloro 6 methylquinoline 3 carboxylate
6
Ethyl 2 (2 chloro 1,4 dihydro 1,4 dioxonaphthalen 3 ylamino) 4 phenylthiazole 5 carboxylate
8
Crystal structure of ethyl 2 chloro 5,8 dimethoxyquinoline 3 carboxylate
8
Ethyl 4 chloro 2 [(4 nitrophenyl)hydrazono] 3 oxobutyrate
8
Synthesis and structure of 1 (2 bromophenyl) 2 chloro 3 (2 chloracetyl) 1H indole
11
Ethyl 2 {1,3 bis[(6 chloro 3 pyridyl)methyl]imidazolidin 2 ylidene} 2 cyanoacetate ethanol solvate
9
5 Chloro 3 ethylsulfinyl 2 (3 fluorophenyl) 1 benzofuran
10
(Z) Ethyl 4 chloro 3 oxo 2 (2 o tolylhydrazono)butanoate
7
Trace Level Quantification of Genotoxic Impurity “3 Chloro N (2 ((2 Dimethylamino) Ethyl) (Methyl) Amino) 4 Methoxy 5 ((4 (1 Methyl 1h Indol 3 Yl) Pyrimidin 2 Yl) Amino) Phenyl) Propanamide” in Osimertinib Mesylate by UPLC QDa
12
3 (2 Chloro 4 hydroxyphenyl) 1 thioisocoumarin
7
Crystal structures of ethyl (2S*,2′R*) 1′ methyl 2′′,3 dioxo 2,3 dihydrodispiro[1 benzothiophene 2,3′ pyrrolidine 2′,3′′ indoline] 4′ carboxylate and ethyl (2S*,2′R*) 5′′ chloro 1′ methyl 2′′,3 dioxo 2,3 dihydrodispiro[1 benzothiophene 2,3′ pyrrolidine 2′,3′′ indoline] 4′ carboxylate
16
2 Chloro N (2 chlorobenzoyl) N (2 ethyl 4 oxo 3,4 dihydroquinazolin 3 yl)benzamide
10
(Z) Ethyl 2 chloro 2 [2 (4 methylphenyl)hydrazinylidene]acetate
8
(Z) Ethyl 4 chloro 2 [(4 chlorophenyl)hydrazono] 3 oxobutanoate
6
Ethyl 4 chloro 2 [(2 nitrophenyl)hydrazono] 3 oxobutyrate
8
(Z) Ethyl 4 chloro 2 [2 (2 methoxyphenyl)hydrazono] 3 oxobutanoate
10
Methyl 3 (2 chloro 5 ethyl 3 pyridyl) 3 hydroxy 2 methylenepropanoate
7
(2E) 3 (2 Chloro 7 methylquinolin 3 yl) 1 (6 chloro 2 methyl 4 phenylquinolin 3 yl)prop 2 en 1 one ethanol monosolvate
12